Fewer community-acquired colds with daily consumption of lactiplantibacillus plantarum heal9 and lacticaseibacillus paracasei 8700:2. a randomized, placebo-controlled clinical trial

HIGHLIGHTS

• who: HEAL, and Lacticaseibacillus, paracasei from the Probi AB, Lund, SwedenProbi AB, Lund, Sweden have published the research work: Fewer Community-Acquired Colds with Daily Consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A Randomized, Placebo-Controlled Clinical Trial, in the Journal: (JOURNAL)
• what: The authors aimed to confirm the previously reported beneficial effects of Lactiplantibacillus plantarum and 8700:2 against community-acquired common colds and identify a possible mechanism of action. This study design included a more controlled evaluation of the incidence and severity of the cold episodes compared to the previously . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.